A study published in the journal Molecules highlights the potential of two cannabis-derived compounds, cannabinol (CBN) and cannabigerol (CBG), in combating acute myeloid leukemia. “Several cannabis plant-derived compounds, especially cannabinoids, exhibit therapeutic potential in numerous diseases and conditions”, states the study’s abstract. “In particular, THC and CBD impart palliative, antiemetic, as well as anticancer effects. …
Category: News
Jan 07 2025
Delaware and Minnesota Remain On Track to Launch Recreational Marijuana Markets This Year.
Since the start of the new year, marijuana agency heads in both Delaware and Minnesota have stepped down. Even so, both states remain on track to launch licensed recreational marijuana sales in the coming months. Currently, 21 states have active recreational marijuana markets, with Delaware and Minnesota set to join that list later this year. …
Jan 07 2025
Illinois House Rejects Bill to Tighten Hemp Regulations, Including Delta-8 THC
Legislation that would have imposed strict regulations on hemp-derived THC products has failed to advance in the final moments of the 103rd General Assembly’s lame-duck session. Despite passing the state Senate 54 to 1 in May, and despite the backing of Governor J.B. Pritzker, the bill encountered resistance within the House’s Democratic supermajority. The legislation, …
Jan 07 2025
Florida Senate Bill Filed to Protect Parental Rights of Medical Marijuana Patients
State Senator Tina Polsky (D), Vice Chair of the Appropriations Committee on Transportation, Tourism, and Economic Development, filed Senate Bill 146 today, aiming to protect the parental rights of qualified medical marijuana patients in Florida. The proposed legislation would amend section 39.806 of the Florida Statutes to prohibit courts from denying or restricting a parent’s …
Jan 07 2025
U.S. 5th Circuit Court of Appeals Again Rules Prosecuting Marijuana Users for Gun Possession Violates Second Amendment
The U.S. Court of Appeals for the 5th Circuit has once again ruled that prosecuting individuals for gun possession based solely on marijuana use violates the Second Amendment. This decision, issued by a three-judge panel, reverses the conviction of Patrick Darnell Daniels Jr., a Mississippi resident sentenced to nearly four years in prison under 18 …
Jan 07 2025
Maine Marijuana Sales Pass $20 Million in December, Bringing 2024 Total to Over $240 Million
In Maine, the over $20 million in legal marijuana sold in December brought the total for 2024 to above $240 million. There was $20,154,122 worth of legal marijuana sold in December in Maine, including $11.28 million in “usable cannabis” (flower, pre-rolls and shake/trim), $5.6 million in concentrates and $3.25 million in infused products (edibles, drinks, …
Jan 07 2025
FLUENT Unveils Bag-O, a New Value Brand for Florida Medical Marijuana Patients, Launching Today
Cansortium Inc., a vertically integrated, multi-state cannabis company operating under the FLUENT brand, today announced the launch of Bag-O, a new value-focused line of premium cannabis flower, available to Florida medical marijuana patients starting today, January 7. “With an emphasis on quality and affordability, Bag-O offers patients access to cannabis at competitive prices, expanding FLUENT’s …
Jan 07 2025
Nevada: $800 Million in Legal Marijuana Sold in 2024, $120 Million in Taxes Garnered
Nevada had another strong year of legal marijuana sales, topping $800 million for the third straight year. Data from the Nevada Cannabis Information Portal shows that there was $636,604,252 worth of marijuana sold legally in Nevada between January and September. According to the research firm Headset, the state sold an additional $165,276,918 between October and …
Jan 07 2025
Cannabis Testing Market to Grow in Value From $2.5 Billion in 2024 to $12 Billion in 2034
The global cannabis testing services market is projected to expand from $2.5 billion in 2024 to over $12 billion by 2034, reflecting a robust compound annual growth rate (CAGR) of 17.26%. This growth is fueled by the increasing legalization of cannabis worldwide, heightened awareness of safety and quality standards, and advancements in testing technologies, according …
Jan 07 2025
Clinical Trial: Psilocybin Shows Sustained Benefits in Treating Depression Over Six Months
A phase 2 clinical trial published in eClinicalMedicine and the US National Library of Medicine shows that psilocybin may be effective in treating severe depression. The study, conducted by researchers from Imperial College London, University of California San Francisco, Johns Hopkins School of Medicine, and McGill University, involved 59 participants. Patients were randomly assigned to …